Case Report of 20 Cases of ECMO in the Treatment of Severe Adenovirus Pneumonia Complicated with ARDS
10.3760/cma.j.cn211501-20191003-02784
- VernacularTitle:体外膜肺氧合治疗重症腺病毒肺炎合并急性呼吸窘迫综合征患儿的护理体会
- Author:
Yanru GAN
1
;
Xiao CHUN
;
Jingxiang MA
;
Tian LI
;
Wanqiu LIANG
;
Lian LIU
Author Information
1. 广州市妇女儿童医疗中心PICU 510623
- From:
Chinese Journal of Practical Nursing
2020;36(11):833-837
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To summarize the clinical nursing experience of oxygenation (ECMO) adjuvant therapy in children with acute respiratory distress syndrome (ARDS) caused by severe adenovirus pneumonia.Method:The clinical data of 20 children with severe adenovirus pneumonia complicated with ARDS who received ECMO in our hospital from April 2017 to May 2019, including general conditions, pre-treatment, complications and prognosis, were retrospectively analyzed.Results:The primary disease of 20 patients was severe adenovirus pneumonia, and the average duration of ECMO treatment was [247.50(152.00,296.75)] hours. After treatment, 12 (12/20) patients successfully escaped from ECMO, 11 (11/20) patients died, and 9 (9/20) died. Complications occurred in 17 (17/20) patients with ECMO treatment. After discharge from the hospital for six months to two years, 9 patients with good quality of life, social function, normal mental development, 2 patients with ischemia and hypoxia brain damage, in the hospital or family continued rehabilitation exercise.Conclusions:Children with severe adenovirus pneumonia combined with ARDS are critically ill. When other treatments are ineffective, ECMO treatment can provide cardiopulmonary support for children with reversible cardiopulmonary failure, but the complications are numerous and serious. Prevention and reduction of related complications are the key to the success of ECMO.
